The filing itself is routine and not directly actionable. Monitor for the executed Form 4 to confirm the sale actually occurred, the ~$1.44M amount is small relative to market cap and likely tax-motivated option exercise covering. No bearish read-through for RVMD from this isolated insider filing.
RVMD drugs
RVMD drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 12 $153.87entry
- T+1 · 5mo ago +4.02%α +2.26% · $160.06
- T+5 · 5mo ago +5.93%α +5.25% · $162.99
- T+20 · 4mo ago +21.45%α +19.67% · $186.88
- T+60 · 2mo ago +34.74%α +31.47% · $207.32
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Director Margaret A. Horn files Form 144 notice of intent to sell 10,000 shares (~$1.44M based on stated value). This is a relatively modest sale relative to the $30.7B market cap, representing ~0.00003% of shares outstanding. The shares are being sold to cover option exercise costs, a routine insider transaction pattern.
Key Facts
- Director Margaret A. Horn filed Form 144 on 2026-06-11
- Proposed sale of 10,000 shares with approximate value of $1,441,900
- Shares to be sold through Morgan Stanley Smith Barney LLC
- Sale is to cover costs of exercising stock options (cash exercise)
- Horn not a named executive officer, holds board director role
Financial Impact
~$1.44M proposed sale value; director ownership stake undisclosed but likely moderate at ~$30.7B market cap
Risk Factors
- Insider may be incrementally reducing exposure ahead of any near-term clinical data readout
- Form 144 is intent-to-sell only; sale may not execute if conditions change
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-005947 |
| Document: 0001950047-26-005947-index.html | 0001950047-26-005947 |
| Document: 0001950047-26-005947.txt | 0001950047-26-005947 |
Track record
44 reports on RVMD
7 of 10 bullish or bearish reports moved the stock their way by T+60. Best: +31.56% at T+60 after the Apr 21, 2026 report. 17 of 18 went positive at some point.
Filters
- Nov 16, 2026today 144 Neutral 3/10 Entry $167.00 Now $166.87 −0.08% settles Feb 16
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $168.20 Now $166.87 −0.79% settles Feb 12
- Nov 13, 20263d ago Insider Cluster Neutral 2/10 Entry $176.02 Now $166.87 −5.20% settles Feb 12
- Nov 12, 20264d ago 144 Neutral 3/10 Entry $176.35 Now $166.87 −5.38% settles Feb 10
- Nov 5, 202611d ago SC 13G/A Neutral 3/10 Entry $177.65 Now $166.87 −6.07% settles Feb 3
- Nov 4, 202612d ago 8-K Bullish 7/10 No price data
- Nov 4, 202612d ago Press Release Neutral 5/10 Entry $177.65 Now $166.87 −6.07% settles Feb 3
- Oct 30, 202617d ago SC 13G Neutral 3/10 Entry $191.31 Now $166.87 −12.78% settles Jan 28
- Oct 23, 202624d ago Institutional Cluster Bullish 4/10 Entry $186.99 Now $166.87 −10.76% settles Jan 21
- Oct 21, 202626d ago Press Release Neutral 1/10 Entry $187.69 Now $166.87 −11.09% settles Jan 20
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers